on SANOFI-AVENTIS (EPA:SAN)
Sanofi Nominates Christel Heydemann as Independent Director
Sanofi's Board of Directors has proposed the appointment of Christel Heydemann as an independent director. This decision is set to be confirmed at the next Annual General Meeting on April 29, 2026. The Board also plans to renew the mandates of Christophe Babule and Jean-Paul Kress.
Patrick Kron will step down from his role at the upcoming meeting. The Board expressed gratitude for his contributions over 12 years. Heydemann, the current CEO of Orange Group, brings extensive experience from roles at Alcatel-Lucent and Schneider Electric.
Her background in industrial and digital transformation is expected to be instrumental for Sanofi's future growth. The Board, maintaining gender parity, comprises 16 members, including two employee representatives. Committee compositions will be reviewed after the meeting.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SANOFI-AVENTIS news